Takeda Pharmaceutical Q2 2024 GAAP EPS ¥134.00 Up From ¥111.00 YoY, Sales ¥.176T Beat ¥1.084T Estimate

+0.08% Post

Takeda Pharmaceutical Company Limited

TAK

13.25

+0.08%

0.00% Post

Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of ¥134.00 per share. This is a 20.72 percent increase over earnings of ¥111.00 per share from the same period last year. The company reported quarterly sales of ¥1.176 trillion which beat the analyst consensus estimate of ¥1.084 trillion by 8.48 percent. This is a 12.75 percent increase over sales of ¥1.043 trillion the same period last year.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.